Title

Summary

Biopacemakers: The race to replace the electronic pacemaker

They have their uses and have saved many lives, but electronic pacemakers are not perfect: they ...[more]

Expert opinion

Giving us his opinion on the health of the investment markets for medical devices is Andrew Fras...[more]

Percardia Inc

Percardia is not afraid of the direct approach. When all the coronary arteries are diseased, and...[more]

To the heart of innovation

Gazing into a crystal ball and giving their views on Cardiovascular Innovations are three wise m...[more]

Next generation innovation at Charing Cross

New technologies get an airing at the Innovation Showcase Forum, part of Tuesday’s programme at ...[more]

Spiralling into control

Like a bullet fired from a gun, it is becoming clear that natural blood flow has a spiral motion...[more]

Mapping the ‘heartscape’

Like the cartographers of the last few centuries who mapped the features of the landscape, a new...[more]

Clinic imminent for Vascular Reconditioning

The arteries are not the first place that anyone would expect to find a shining light, but that ...[more]

The next fashion in stent coats

Stents with biodegradable coatings are forecast by some experts to supersede existing drug-eluti...[more]

Aptus raises $19.5 million for AAA clinical trial

Sunnyvale, CA-based Aptus Endosystems has closed a $19.5 million series B round. The company, wh...[more]